Amneal Pharmaceuticals, Inc.

Healthcare

NASDAQ:AMRX · NASDAQ Global Select

Market Cap $4.89B Beta 1.32 P/E (TTM) 43.5

$16.20 -0.86%

-$0.14 today

52W Low $7.67High $16.61

Vol 2.24M · Avg 1.74M

EPS (TTM)$0.37

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+109.03%

Period High

$16.34

Period Low

$7.75

Latest

$16.20

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Lantheus Holdings, Inc.

NASDAQ:LNTH

$6.80B

Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

$4.99B

Indivior Pharmaceuticals Inc

NASDAQ:INDV

$4.80B

Envista Holdings Corp

NYSE:NVST

$4.00B

Telix Pharmaceuticals Limited

NASDAQ:TLX

$3.24B

Dyne Therapeutics, Inc.

NASDAQ:DYN

$3.01B

Soleno Therapeutics, Inc.

SLNO

$2.76B

Supernus Pharmaceuticals, Inc.

NASDAQ:SUPN

$2.58B

Bausch Health Companies Inc.

NYSE:BHC

$1.89B

Perrigo Company plc

NYSE:PRGO

$1.52B

What is the latest AMRX filing?

The latest filing shown is 4 dated May 12, 2026.

How many recent filings does AMRX have?

Intrinsic Alpha currently shows 20 recent filings for AMRX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.